Takeaway: We will be hosting a conversation with Jonathan Sandelman, the CEO of Ayr Strategies, today at 2 PM ET.
AYRWF is a Hedgeye Cannabis Best Idea LONG.
|
CLICK HERE for event details (includes video, dial-in info, and materials link) |
Topics of discussion and questions will include:
- Looking past the recent acquisitions, how will the company's focus shift to the other limited license and highly populated states of IL, MI, NY, and MD?
- What are the essential criteria for entering a new state like NY?
- Ayr has a relentless focus on quality business that generates a significant ROI. The company has paid between 1.0 and 3.2x NTM (A) EBITDA for its recent acquisitions. Can those multiples be achieved in 2021, given the new (green) rush to buy cannabis assets (was FL an exception or the new norm?)
- Buying substantial assets would appear to be more important than investing in adjacent states?
- Ayr is acquiring product/operational expertise that can be deployed across the existing portfolio. What functional holes need to be filled in, if any?
- Where can operational efficiencies be realized in the current portfolio?
- What is the MA and NJ conversion from medical to recreational opportunity?
